foscarnet has been researched along with fluorodeoxyglucose f18 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baroli, A; Bulzonetti, N; Carletti, R; Di Gioia, C; Durante, C; Filetti, S; Gianfrilli, D; Giannetta, E; Graziadio, C; Isidori, AM; Lenzi, A; Longo, F; Pofi, R; Tombolini, V; Verrienti, A | 1 |
1 other study(ies) available for foscarnet and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Fluorodeoxyglucose F18; Foscarnet; Humans; Positron Emission Tomography Computed Tomography; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2017 |